Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange

Carol J. Levy, Nicole C. Foster, Stephanie N. DuBose, Shivani Agarwal, Sarah K. Lyons, Anne L. Peters, Gabriel I. Uwaifo, Linda A. DiMeglio, Jennifer L. Sherr, Sarit Polsky

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Objectives: To examine changes in device use and glycemic outcomes for pregnant women from the T1D Exchange Clinic Registry between the years 2010-2013 and 2016-2018. Methods: Participant-reported device use and glycemic outcomes were compared for women aged 16-40 years who were pregnant at the time of survey completion, comparing 2010-2013 (cohort 1) and 2016-2018 (cohort 2). Hemoglobin A1c results within 30 days prior to survey completion were obtained from medical records. Results: There were 208 pregnant women out of 5,236 eligible participants completing the questionnaire in cohort 1 and 47 pregnant women out of 2,818 eligible participants completing the questionaire in cohort 2. Continuous glucose monitor (CGM) use while pregnant trended upward among cohort 2 (70% vs 37%, P =.02), while reported continuous subcutaneous insulin infusion (CSII) use while pregnant declined (76% vs 64%, P =.04). HbA1c levels trended downward (6.8% cohort 1 vs 6.5% cohort 2, P =.07). Conclusions: Self-reported CGM use while pregnant increased over the studied intervals whereas CSII use decreased. Additional evaluation of device use and the potential benefits for T1D pregnancies is needed.

Original languageEnglish (US)
Pages (from-to)1297-1302
Number of pages6
JournalJournal of Diabetes Science and Technology
Issue number6
StatePublished - 2020


  • continuous glucose monitor
  • female
  • pregnancy
  • type 1 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Bioengineering
  • Biomedical Engineering


Dive into the research topics of 'Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange'. Together they form a unique fingerprint.

Cite this